You are here

hot flashes

FDA adds liver injury warning for Veozah

Beckers Hospital Review

Wed, 12/18/24 - 11:26 am

Detailed trial data show Bayer drug alleviates menopause symptoms

BioPharma Dive

Thu, 05/16/24 - 09:43 pm

clinical trials

Bayer cues up filings for rival to Astellas’ menopause drug

Pharmaphorum

Tue, 03/19/24 - 11:35 am

Bayer's menopausal relief drug succeeds in late-stage trial

Reuters

Mon, 01/8/24 - 11:23 am

clinical trials

A New Drug For Menopausal Hot Flashes, Veozah, Faces Access Challenges

Forbes

Tue, 10/24/23 - 07:49 pm

Astellas rolls out national Veozah campaign for treating menopause symptoms

Medical Marketing and Media

Mon, 10/9/23 - 10:04 am

Astellas reports data from Phase IIIb trial to treat VMS due to menopause

Clinical Trials Arena

Wed, 06/28/23 - 09:58 am

clinical trials

Astellas' Menopause Drug Scores FDA Approval, After Regulatory Setback

Yahoo/Benzinga

Mon, 05/15/23 - 11:21 am

Cash-strapped Acer sees menopause drug flunk phase 2 trial

Fierce Biotech

Fri, 03/17/23 - 11:41 am

Acer Therapeutics

clinical trials

What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision

Endpoints

Wed, 11/2/22 - 11:00 pm

patient education

Astellas reports Phase III data of fezolinetant for menopause-linked VMS

Clinical Trials Arena

Tue, 09/6/22 - 10:50 am

clinical trials

vasomotor symptoms

Astellas' menopause therapy accepted for FDA review 5 months after late-phase study mars record

Fierce Biotech

Thu, 08/18/22 - 12:40 pm

clinical trials

Astellas' menopause drug suffers rare setback as failed Asian trial blots previously pristine record

Fierce Biotech

Tue, 03/15/22 - 10:41 am

clinical trials

Astellas’ eyes filings for menopause drug fezolinetant after ph3 win

Pharmaforum

Mon, 03/7/22 - 10:07 am

clinical trials

FDA approval, global partnership on the agenda at Mithra as phase 3 menopause trials hit goals—with one blemish

Fierce Biotech

Fri, 01/14/22 - 11:18 am

clinical trials

Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff

Endpoints

Fri, 02/19/21 - 10:27 am

clinical trials

Bayer inks $425M upfront KaNDy buyout to challenge Astellas for menopause market

Fierce Biotech

Tue, 08/11/20 - 01:30 pm

KaNDy Therapeutics

Concept Device Designed to Tame Menopausal Hot Flashes

Medical Devices and Diagnostics Industry

Sat, 12/1/18 - 12:24 pm

Cambridge Consultants

Astellas swoops in on a mid-stage drug for hot flashes in $860M biotech buyout deal

Endpoints

Mon, 04/3/17 - 09:23 am

Pfizer: The Menopause Opportunity

Seeking Alpha

Fri, 10/18/13 - 06:19 pm

Ligand Pharmaceuticals

Pages